- Home
- CENT vs CGON Comparison
CENT vs CGON Comparison
Compare CENT & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENT
- CGON
- Stock Information
- Founded
- CENT 1955
- CGON 2010
- Country
- CENT United States
- CGON United States
- Employees
- CENT N/A
- CGON N/A
- Industry
- CENT Consumer Specialties
- CGON
- Sector
- CENT Consumer Discretionary
- CGON
- Exchange
- CENT Nasdaq
- CGON NYSE
- Market Cap
- CENT 2.4B
- CGON 2.1B
- IPO Year
- CENT N/A
- CGON 2024
- Fundamental
- Price
- CENT $34.44
- CGON $25.55
- Analyst Decision
- CENT Strong Buy
- CGON Strong Buy
- Analyst Count
- CENT 2
- CGON 10
- Target Price
- CENT $42.50
- CGON $64.44
- AVG Volume (30 Days)
- CENT 78.9K
- CGON 784.3K
- Earning Date
- CENT 08-06-2025
- CGON 08-07-2025
- Dividend Yield
- CENT N/A
- CGON N/A
- EPS Growth
- CENT N/A
- CGON N/A
- EPS
- CENT 1.87
- CGON N/A
- Revenue
- CENT $3,155,810,000.00
- CGON $662,000.00
- Revenue This Year
- CENT $0.42
- CGON N/A
- Revenue Next Year
- CENT $1.77
- CGON $14,719.70
- P/E Ratio
- CENT $18.32
- CGON N/A
- Revenue Growth
- CENT N/A
- CGON 224.51
- 52 Week Low
- CENT $31.97
- CGON $14.80
- 52 Week High
- CENT $43.88
- CGON $40.47
- Technical
- Relative Strength Index (RSI)
- CENT 42.44
- CGON 48.31
- Support Level
- CENT $34.06
- CGON $25.02
- Resistance Level
- CENT $34.78
- CGON $26.97
- Average True Range (ATR)
- CENT 0.73
- CGON 1.14
- MACD
- CENT -0.19
- CGON -0.18
- Stochastic Oscillator
- CENT 13.87
- CGON 17.79
About CENT Central Garden & Pet Company
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.